GLP-1 Coverage & Costs in District of Columbia (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm District of Columbia at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
District of Columbia Medicaid Coverage for GLP-1
Medicaid: not covered as of January 2026 (KFF)
KFF's map lists the District of Columbia as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Your Options in District of Columbia:
- Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves District of Columbia
- Commercial or employer insurance: check your plan's drug list and prior authorization rules
- Medicare GLP-1 Bridge for eligible Part D enrollees (see below)
District of Columbia Medicaid GLP-1 Prescriptions in 2025
27,754
#44
$22.0 million
Ozempic
District of Columbia Medicaid paid for 27,754 GLP-1 prescriptions in 2025, 0.2% of the 11.26 million paid nationally and number 44 of 51 (50 states and DC). It reimbursed pharmacies $22.0 million before manufacturer rebates, about $794 per prescription, and the most-filled product was Ozempic. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 538 of those prescriptions (1.9%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, District of Columbia Medicaid GLP-1 prescriptions went from 13,307 to 27,754, 2.1 times the 2021 count. From 2024 to 2025 the count fell by 2,310.
13,307
18,465
21,943
30,064
27,754
| Product | DC Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Ozempic | 15,986 | 57.6% |
| Mounjaro | 5,681 | 20.5% |
| Trulicity | 5,232 | 18.9% |
| Zepbound | 358 | 1.3% |
| Rybelsus | 303 | 1.1% |
| Wegovy | 180 | 0.6% |
| Bydureon | 14 | 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
District of Columbia Employee Plan and Insurer GLP-1 Rules
We have not read the District of Columbiastate employee health plan's own documents, so we do not state whether it covers GLP-1s for weight loss. State employees can ask their benefits office or check the plan's drug list.
We have no District of Columbiainsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.
Comparing self-pay programs in District of Columbia?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for District of Columbia
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for District of Columbia. The rest record a state count without naming the states, so confirm District of Columbia with the program at intake before you pay.
What Programs' Own Pages Say About District of Columbia
4 of the 8 programs whose own pages name the states they serve include District of Columbia: MangoRx, Wellorithm, MEDGm, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | District of Columbia |
|---|---|
| Willow | DC not named |
| SnagRx | DC not named |
| Strut Health | DC not named |
| MangoRx | Ships to DC |
| Wellorithm | Serves DC |
| MEDGm | Serves DC |
| TelosRx | DC not named |
| Trimi | Serves DC |
Trimi's state table lists District of Columbia as served through the Arora Health network. Visit format there: Online evaluation through the Arora Health network. The telehealth law it cites for District of Columbia is D.C. Code 3-1201.05(b). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in District of Columbia
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in District of Columbia, 2024
District of Columbia prescribers wrote 34,054 Medicare Part D GLP-1 claims in 2024, number 49 of 51, with $45.1 million in gross drug cost before rebates. Ozempic led with 16,052 claims for 3,443 enrollees. Wegovy had 310 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | DC Part D claims | Enrollees |
|---|---|---|
| Ozempic | 16,052 | 3,443 |
| Trulicity | 8,993 | 2,001 |
| Mounjaro | 6,221 | 1,340 |
| Rybelsus | 1,676 | 481 |
| Victoza | 399 | Not given |
| Wegovy | 310 | 92 |
| Liraglutide | 217 | 103 |
| Bydureon Bcise | 165 | 40 |
| Byetta | 21 | Not given |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in District of Columbia
The Bridge is national, so the rules are the same in District of Columbia as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How District of Columbia Compares to Other Mid-Atlantic States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how District of Columbia and its neighbors in the Mid-Atlantic are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| District of Columbia (this page) | Not covered | 27,754 |
| Delaware | Covered, January 2026 (KFF) | 55,674 |
| Maryland | Not covered | 148,487 |
| Virginia | Covered, January 2026 (KFF) | 227,472 |
| West Virginia | Not covered | 94,999 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
GLP-1 Guides for District of Columbia Cities
If Your Insurance Denies GLP-1 Coverage in District of Columbia
Commercial plans offer an internal appeal, then external review; District of Columbia Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in District of Columbia
- District of Columbia Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: we have not read the plan's documents; ask the benefits office.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in District of Columbia
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in District of Columbia.
Frequently Asked Questions — District of Columbia
Does District of Columbia Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did District of Columbia Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in District of Columbia in 2024?
What is the cheapest way to get GLP-1 medication in District of Columbia?
Which online GLP-1 programs serve District of Columbia?
Does Medicare cover GLP-1s in District of Columbia?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.